# Diuretic Strategies in Acute Heart Failure Patients at High Risk for Diuretic Resistance

> **NCT05986773** · PHASE4 · TERMINATED · sponsor: **Stadtspital Zürich** · enrollment: 13 (actual)

## Conditions studied

- Acute Heart Failure
- Diuretic Resistance

## Interventions

- **DRUG:** Furosemide
- **DRUG:** Metolazone
- **DRUG:** Acetazolamide

## Key facts

- **NCT ID:** NCT05986773
- **Lead sponsor:** Stadtspital Zürich
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2023-10-10
- **Primary completion:** 2024-12-31
- **Final completion:** 2024-12-31
- **Target enrollment:** 13 (ACTUAL)
- **Why stopped:** Low recruitment in both centers
- **Last updated:** 2025-02-14

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05986773

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05986773, "Diuretic Strategies in Acute Heart Failure Patients at High Risk for Diuretic Resistance". Retrieved via AI Analytics 2026-08-18 from https://api.ai-analytics.org/clinical/NCT05986773. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*